MedTrace Logo

EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study

NCT03298477 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2026-05-19

Study results available
· View outcomes & findings →

Summary

Prospective, multicenter, single arm study with consecutive, eligible subject enrollment at each site. All subjects will undergo the Endovascular Aneurysm repair procedure with the Nellix System.

Conditions

  • Abdominal Aortic Aneurysm Without Rupture

Interventions

DEVICE

Nellix® System

Endovascular Abdominal Aortic Aneurysm Repair using the Nellix® System

Sponsors & Collaborators

  • Endologix

    lead INDUSTRY

Principal Investigators

  • Jeffrey Carpenter, MD · Cooper Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2022-06-07
Completion
2025-08-16
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03298477 on ClinicalTrials.gov